Kaken Pharmaceutical Co Stock Performance
| KKPCF Stock | USD 26.00 0.00 0.00% |
Kaken Pharmaceutical has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.48, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Kaken Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kaken Pharmaceutical is expected to be smaller as well. Kaken Pharmaceutical right now secures a risk of 2.79%. Please verify Kaken Pharmaceutical Co variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and rate of daily change , to decide if Kaken Pharmaceutical Co will be following its current price movements.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Kaken Pharmaceutical Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Kaken Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
| Quick Ratio | 4.85 | |
| Fifty Two Week Low | 27.15 | |
| Payout Ratio | 62.35% | |
| Fifty Two Week High | 39.84 | |
| Trailing Annual Dividend Yield | 535.71% |
Kaken |
Kaken Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,400 in Kaken Pharmaceutical Co on November 14, 2025 and sell it today you would earn a total of 200.00 from holding Kaken Pharmaceutical Co or generate 8.33% return on investment over 90 days. Kaken Pharmaceutical Co is currently producing 0.1626% returns and takes up 2.7868% volatility of returns over 90 trading days. Put another way, 25% of traded pink sheets are less volatile than Kaken, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Kaken Pharmaceutical Target Price Odds to finish over Current Price
The tendency of Kaken Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 26.00 | 90 days | 26.00 | about 15.67 |
Based on a normal probability distribution, the odds of Kaken Pharmaceutical to move above the current price in 90 days from now is about 15.67 (This Kaken Pharmaceutical Co probability density function shows the probability of Kaken Pink Sheet to fall within a particular range of prices over 90 days) .
Kaken Pharmaceutical Price Density |
| Price |
Predictive Modules for Kaken Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kaken Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaken Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kaken Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kaken Pharmaceutical is not an exception. The market had few large corrections towards the Kaken Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kaken Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kaken Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.10 | |
β | Beta against Dow Jones | 0.48 | |
σ | Overall volatility | 1.26 | |
Ir | Information ratio | 0.02 |
Kaken Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kaken Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kaken Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 13.0% of the company outstanding shares are owned by corporate insiders |
Kaken Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kaken Pink Sheet often depends not only on the future outlook of the current and potential Kaken Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaken Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Last Dividend Date | 30th of March 2023 | |
| Trailing Annual Dividend Rate | 150.00 | |
| Float Shares | 30.87M | |
| Trailing Annual Dividend Yield | 535.71% |
Kaken Pharmaceutical Fundamentals Growth
Kaken Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kaken Pharmaceutical, and Kaken Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kaken Pink Sheet performance.
| Return On Equity | 6.65 | |||
| Return On Asset | 6.36 | |||
| Profit Margin | 12.00 % | |||
| Operating Margin | 22.04 % | |||
| Current Valuation | (68.22 B) | |||
| Shares Outstanding | 37.47 M | |||
| Price To Earning | 16.87 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 75.78 B | |||
| EBITDA | 19.23 B | |||
| Cash And Equivalents | 73.7 B | |||
| Total Debt | 3.85 B | |||
| Debt To Equity | 0.03 % | |||
| Cash Flow From Operations | 13.34 B | |||
| Earnings Per Share | 1.66 X | |||
About Kaken Pharmaceutical Performance
By analyzing Kaken Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Kaken Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kaken Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kaken Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan. Kaken Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1164 people.Things to note about Kaken Pharmaceutical performance evaluation
Checking the ongoing alerts about Kaken Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kaken Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 13.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kaken Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kaken Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Kaken Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kaken Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kaken Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kaken Pharmaceutical's pink sheet. These opinions can provide insight into Kaken Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kaken Pink Sheet analysis
When running Kaken Pharmaceutical's price analysis, check to measure Kaken Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaken Pharmaceutical is operating at the current time. Most of Kaken Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Kaken Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kaken Pharmaceutical's price. Additionally, you may evaluate how the addition of Kaken Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |